MedPath

Multicenter study of inhibitory effect of DPP-4 inhibitor (and/ ARB) on hepatic fibrosis in patients with diabetes and liver dysfunctio

Not Applicable
Recruiting
Conditions
Diabetes Mellitus Liver dysfunction Hypertension
Registration Number
JPRN-UMIN000008068
Lead Sponsor
Third department of Internal Medicine, Nara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with co-infection with hepatitis B virus 2) Patients with co-infection with hepatitis C virus 3) Patients with autoimmune hepatitis, primary biliary cirrhosis 4) Patients with alcohol addict (more than 20g/day) 5) Patients with insulin therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath